On Monday,
Tilray, Inc. (NASDAQ:TLRY) and
Aphria, Inc. (NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion. Benzinga spoke with
Irwin Simon, CEO of the new combined company.
Check out the video below:
Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23.
Jazz Pharmaceuticals (NASDAQ:JAZZ) finalized its acquisition of
GW Pharmaceuticals plc. (NASDAQ:GWPH), the producer of the FDA‑approved prescription cannabidiol drug Epidiolex, for $7.2 billion or $6.7 billion net of GW Pharma s cash.
Meanwhile,
Ascend Wellness Holdings (CSE:AAWH) started trading on the Canadian Securities exchange following a raise of approximately $80 million through an initial public offering of roughly 10 million shares of its Class A common stock at $8 per share.
Condori pide revisión antidroga en la Gobernación, la FELCN no encuentra sustancias controladas - La Razón
la-razon.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from la-razon.com Daily Mail and Mail on Sunday newspapers.
El gobernador visitó el Oeste provincial
elesquiu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elesquiu.com Daily Mail and Mail on Sunday newspapers.
El Colegio Divina Pastora crea un cinturón anticovid
leonoticias.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from leonoticias.com Daily Mail and Mail on Sunday newspapers.